BSE filing, NSE: SSORGS. Summary written from the filing by ALFA Finder's alert engine.
Oxygenta Pharmaceutical Ltd: key numbers
- Share price
- ₹48.50
- Market cap
- ₹179.4 Cr
- Revenue (annual)
- ₹113.0 Cr
- Net profit (annual)
- ₹-17.57 Cr
- P/E (TTM)
- -13.2×Sector 47.2×
- Promoter holding
- 56.54%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Oxygenta Pharmaceutical Ltd
All →Oxygenta Pharmaceutical Other Announcement
The company filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Oxygenta Pharmaceutical Acquisition Worth ₹6.75 Cr
Oxygenta Pharmaceutical acquired land in Telangana from TGIIC for Rs. 6.75 Crore. The purchase supports business expansion and long-term strategic infrastructure needs.
- Value
- ₹6.75 Cr
Oxygenta Pharmaceutical Annual General Meeting
Oxygenta Pharmaceutical Limited conducted its 33rd Annual General Meeting on August 21, 2026, via video conferencing to discuss and adopt various corporate business resolutions.
Oxygenta Pharmaceutical Annual Report
Oxygenta Pharmaceutical has submitted its 33rd Annual Report for FY 2025-26, including the notice for the upcoming Annual General Meeting scheduled for August 21, 2026.
Oxygenta Pharmaceutical Annual General Meeting
Oxygenta Pharmaceutical Limited announced its 33rd Annual General Meeting scheduled for August 21, 2026. The notice includes director appointments and adoption of the company's financial statements.
Oxygenta Pharmaceutical Other Announcement
Oxygenta Pharmaceutical Limited has appointed M/s. PCR & Associates as its Cost Auditor for a 12-month term. This appointment follows the company's recent board meeting.
Other other announcement announcements
All →Asarfi Hospital Other Announcement
Asarfi Hospital Limited filed its half-yearly shareholding pattern under Regulation 31(1)(b) for the period ended 30 September 2026. The filing shows promoter and public holdings, with no transaction or corporate event.
Bombay Dyeing & Manufacturing Company Other Announcement
Bombay Dyeing's RTA, KFin Technologies, is shifting its corporate office to Kokapet, Telangana w.e.f. December 1, 2026. The registered office remains unchanged.
Machino Plastics Other Announcement
Machino Plastics constituted a Borrowing Committee and reconstituted its board committees. The change is routine governance housekeeping with no material business impact.
Hero Motors Other Announcement
Hero Motors intimated that its RTA KFin Technologies is relocating its corporate office to Kokapet, Telangana effective December 2026. No change in RTA name, appointment, or registered office.
Diamond Power Infrastructure Other Announcement
Diamond Power Infrastructure filed its quarterly Monitoring Agency Report for the QIP (₹1,613.97 Cr) confirming all proceeds utilised as per the offer document with no material deviation. The filing is a routine Reg 32(6)/Reg 173A compliance certificate.
Atlanta Electricals Other Announcement
Atlanta Electricals filed its quarterly Monitoring Agency Report for IPO proceeds utilisation for Q1 FY27. No deviations or changes in the objects of the IPO were reported.